Purpose To gain insight into the prevalence and severity of chemotherapy-induced neuropathy and its influence on health-related quality of life (HRQOL) in a population-based sample of colorectal cancer (CRC) survivors 2 to 11 years after diagnosis. Methods All alive individuals diagnosed with CRC between 2000 and 2009 as registered by the Dutch population-based Eindhoven Cancer Registry were eligible for participation. Eighty-three percent (n = 1,643) of patients filled out the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) C30 and the EORTC QLQ Chemotherapy-Induced Peripheral Neuropathy 20. Results The five neuropathy subscale–related symptoms that bothered patients with CRC the most ...
Background Peripheral neuropathy (PN) is a debilitating complication among colorectal cancer (CRC) s...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
Background. Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of oxa...
BACKGROUND: Peripheral neuropathy (PN) is a debilitating complication among colorectal cancer (CRC) ...
Background: Oxaliplatin, combined with capecitabine (CAPOX) or infused 5-fluorouracil (FOLFOX), is s...
Background\ud \ud Prolonged neurotoxicity after systemic chemotherapy has the potential to impact on...
International audience(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Lit...
Background Peripheral neuropathy (PN) is a debilitating complication among colorectal cancer (CRC) s...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
Background. Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of oxa...
BACKGROUND: Peripheral neuropathy (PN) is a debilitating complication among colorectal cancer (CRC) ...
Background: Oxaliplatin, combined with capecitabine (CAPOX) or infused 5-fluorouracil (FOLFOX), is s...
Background\ud \ud Prolonged neurotoxicity after systemic chemotherapy has the potential to impact on...
International audience(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Lit...
Background Peripheral neuropathy (PN) is a debilitating complication among colorectal cancer (CRC) s...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...